https://scholars.lib.ntu.edu.tw/handle/123456789/161626
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor | 臺大醫院-腫瘤醫學部;臺大醫學院-癌症研究中心; | - |
dc.contributor.author | Camidge, Ross | en |
dc.contributor.author | Cappuzzo, Federico | en |
dc.contributor.author | Go, Jowell | en |
dc.contributor.author | Isaacson, Jeffrey | en |
dc.contributor.author | Litten, Jason | en |
dc.contributor.author | Park, Keunchil | en |
dc.contributor.author | Spigel, David R. | en |
dc.contributor.author | Spira, Alexander | en |
dc.contributor.author | Vergnenegre, Alain | en |
dc.contributor.author | Wolf, Juergen | en |
dc.contributor.author | Yang, James Chih-Hsin | en |
dc.contributor.author | Mok, Tony | en |
dc.creator | Camidge, Ross;Cappuzzo, Federico;Go, Jowell;Isaacson, Jeffrey;Litten, Jason;Park, Keunchil;Spigel, David R.;Spira, Alexander;Vergnenegre, Alain;Wolf, Juergen;Yang, James Chih-Hsin;Mok, Tony | en |
dc.creator | 楊志新 | zh-tw |
dc.date | 2015 | - |
dc.date.accessioned | 2017-07-10T06:39:03Z | - |
dc.date.accessioned | 2018-07-09T02:50:04Z | - |
dc.date.available | 2017-07-10T06:39:03Z | - |
dc.date.available | 2018-07-09T02:50:04Z | - |
dc.date.issued | 2015 | - |
dc.identifier.uri | http://ntur.lib.ntu.edu.tw//handle/246246/281035 | - |
dc.language | en-us | - |
dc.relation | J. Thorac. Oncol., 10(9), S427-S427 | - |
dc.relation.ispartof | J. Thorac. Oncol. | - |
dc.subject | T790M | - |
dc.subject | rociletinib | - |
dc.subject | EGFR | - |
dc.subject | NSCLC | - |
dc.title | TIGER-1: A Phase 2/3 Study of First Line Rociletinib or Erlotinib in EGFR-Mutant NSCLC | - |
dc.relation.pages | - | - |
dc.relation.journalvolume | 10 | - |
dc.relation.journalissue | 9 | - |
item.grantfulltext | none | - |
item.fulltext | no fulltext | - |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。